Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause.
Please register your interest here if you would like updates on the meeting or topic
Expand the Toolkit of Conjugate Drugs With Novel Targeting Moiety & Payloads to Improve Tumour Penetration, Expand Disease Indications, & Supercharge the Development of Safer & More Effective Therapeutics
Welcome to the Novel Targeting Moiety & Payload Conjugates Summit Europe
Exploring DACs, AOCs, PDCs, SMDCs, & More!
Join us at the inaugural Novel Targeting Moiety & Payload Conjugate Summit Europe, the premier event for Europe's burgeoning novel drug conjugate market. With more companies than ever before utilising novel targeting moieties and novel payloads to widen the therapeutic index of their conjugate, this meeting will act as your gateway to explore how design approaches range from peptide-drug conjugates, bispecific-drug conjugates, antibody-oligonucleotide conjugates, radio-conjugates, and fragment drug conjugates.
Learn how alterations in the targeting moiety and payload can enhance target specificity and reduce off-target toxicity, improve tumour penetration in solid tumours, prevail over oligonucleotide delivery challenges, and improve PK properties to maximise efficacy and reduce toxicity.
Offering a platform for innovative biotechs to showcase how their technologies can address the challenges limiting the application of ADCs, this meeting will bring together a unique audience of C-level executives from European biotechs, Director through to Scientists from large pharma working on and exploring how to expand the conjugate design toolkit.
As the only event in Europe spotlighting novel conjugate approaches in a room of highly invested individuals; this event is novel by name and nature!
Don't miss out on shaping the future of targeted therapeutics in Europe!
What Your Peers Have to Say:
"For me, it’s sometimes challenging to communicate with the ADC community because they often don’t understand the unique issues I face. This conference offers a rare
opportunity to connect with like-minded experts who truly understand the complexities of working with novel targeting format and payloads"
"This is a great opportunity to showcase our comprehensive platform and innovative payloads. I am eager to share our progress and engage with experts who are working with novel conjugates and payloads at this meeting."